Results 71 to 80 of about 19,649 (164)

The EvIDHence study: real-world treatment patterns and safety outcomes in mutant and wild-type <i>IDH1</i> cholangiocarcinoma before availability of mIDH1 inhibitors. [PDF]

open access: yesESMO Gastrointest Oncol
Sahai V   +21 more
europepmc   +1 more source

Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia. [PDF]

open access: yesBlood Adv
Fries C   +10 more
europepmc   +1 more source

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study. [PDF]

open access: yesEpilepsia Open
Nabbout R   +14 more
europepmc   +1 more source

Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?" [PDF]

open access: yesCancer
Albliwi M   +22 more
europepmc   +1 more source

Response to Letter to the Editor: 'NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial'. [PDF]

open access: yesESMO Open
Macarulla T   +19 more
europepmc   +1 more source

Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]

open access: yesCNS Drugs
Plante DT   +10 more
europepmc   +1 more source

Surgical Whiplash. [PDF]

open access: yesAnn Med Surg (Lond)
Bohler F, Chaiyasate M, Hadid K.
europepmc   +1 more source

Home - About - Disclaimer - Privacy